Feb
08
Treating T3 Deficiency: Thyroid Optimization
By Neal Rouzier, MD High Dose Replacement with thyroid hormone DOES NOT cause harm as demonstrated in interventional studies. The harm of Graves’ disease should not be extrapolated to optimal replacement. Understanding the controversies of thyroid hormone levels and thyroid hormone replacement-that which AACE and your peers do not understand or realize. The last webinar
DETAIL
Jan
11
Treating T3 Deficiency: The Most Important of the Thyroid Webinars So Far
By Neal Rouzier, MD CASE: Your hormonally optimized 45 y/o female patient requests an office visit to discuss her thyroid hormone. Her PMD chastises her for taking thyroid hormone and states that he does not wish to see her anymore as a patient. She relates that upon routine testing of thyroid function, that the TSH
DETAIL
Aug
06
Treating T3 Deficiency: Recent Literature Supports That Low Free T3 was the Highest Independent Predictor of Death in CV Patients
Recommended Pre-Reading: Treating T3 Deficiency, The Evidence You Need Interested in monthly webinars? Upgrade your Membership SCENARIO: A 59 y/o female with CVD is referred by her friend for evaluation of hypothyroidism. Laboratory tests consistently show a mildly elevated TSH and normal Free T4. Despite multiple attempts to try to get her PMD to prescribe a trial
DETAIL
Jul
29
Treating T3 Deficiency: More Proof and Reasoning that T4 Monotherapy Results in Inadequate Conversion and FINALLY the AACE releases a revised statement on Thyroid Treatment
Recommended Pre-Reading: Treating T3 Deficiency: If T4 Does not Improve Symptoms, and Normalizing TSH Does not Guarantee or Infer Improvement in Symptoms, Then How Should we Treat Patients? SCENARIO: A 45 y/o female with persistent symptoms of fatigue, low energy, depression, presents for evaluation of her thyroid hormone therapy. She is referred by her friend
DETAIL
Jul
27
Treating T3 Deficiency: If T4 Does not Improve Symptoms, and Normalizing TSH Does not Guarantee or Infer Improvement in Symptoms, Then How Should we Treat Patients?
Recommended Pre-Reading: Treating T3 Deficiency, The Evidence You Need SCENARIO: Your 41 y/o PCOS patient that is optimized on thyroid returns with concerns that her PMD does not like/approve of DTE. She notes that she is finally feeling well and experiencing success with weight loss. The PMD also is upset with the suppressed TSH level
DETAIL